A patient with metastatic cancer requests experimental treatment not yet approved by the FDA. What is the most appropriate physician response?
-
A
Prescribe the treatment immediately to honor the patient's autonomy
-
B
Explain the evidence status, discuss risks and alternatives, and explore compassionate use or clinical trial enrollment
-
C
Refuse any discussion of unapproved treatments
-
D
Report the patient to the hospital administration